Company news

TransThera Sciences (Nanjing). Inc. news in 2025

TransThera Sciences (Nanjing). Inc.'s news releases, calls and decks from 2025, newest first.

View company

New drug application for Tinengotinib tablets accepted by the national medical products administration

December 18, 2025

TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet

December 4, 2025

Inclusion of Tinengotinib tablets in the list of products for priority review by the national medical products administration

December 3, 2025